Results 61 to 70 of about 325,675 (121)

P163 | SECONDARY PRIMARY MALIGNANCIES IN PATIENTS AFFECTED BY NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION WITH OR WITHOUT MAINTENANCE WITH IMMUNOMODULATORY AGENTS: A TEN-YEAR SINGLE-CENTER EXPERIENCE

Haematologica
Background: Secondary primary malignancies (SPM) in multiple myeloma (MM) patients aroused interest due to the prolonged survival granted by new treatments.
G. Vianello, R. Pasquale, R. Stocchi, D. Di Lorenzo, S. Buttignol, R. Mestroni, E. Favero, R. Fanin, F. Patriarca   +8 more
doaj  

Evaluation of Internal Communication and Importance of the Factors Affecting Credit Risk In Iran’s Riba-Free Banking System [PDF]

تحقیقات مالی اسلامی (پیوسته), 2019
The intensification of credit risk and increasing the volume of non-performing loans of the banking system in recent years creates a potential crisis in the Islamic Republic of Iran’s riba-free banking system.
Ehsan Zakernia, Majid Zeynodini
doaj  

P024 | COMBINATION OF BASELINE CA125 LEVELS AND EOT FDG-PET DYNAMICALLY STRATIFIES FAILURE RISK IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA TREATED WITH DA-EPOCH-R: A REAL-LIFE RETROSPECTIVE ANALYSIS.

Haematologica
Introduction: Modern immune-chemotherapy may cure nearly 85% of patients (pts) with Primary Mediastinal B-cell Lymphoma (PMBCL) but controversies exist regarding optimal frontline regimen and prognostic factors to guide treatment selection.
A. Fresa, M. Bonanni, A. Cuccaro, F. Ibello, D. Donnarumma, U. Falcone, M. Arcamone, S. Crisci, L. Sirica, M. Esposito, F. Volzone, C. Becchimanzi, S. Mele, R. De Filippi, A. Pinto   +14 more
doaj  

The COVID-19 Pandemic: Is It A Wolf Consuming Fertility? [PDF]

International Journal of Fertility and Sterility, 2020
Luigi Napolitano, Biagio Barone, Felice Crocetto, Marco Capece, Roberto La Rocca   +4 more
doaj   +1 more source

SP29 | A RARE MYELOPROLIFERATIVE DISEASE: CHRONIC EOSINOPHILIC LEUKEMIA, NEW GENETIC FEATURES?

Haematologica
Chronic Eosinophilic Leukemia (CEL) is a rare chronic myeloproliferative disease (MPN) characterized by a sustained clonal proliferation of eosinophilic precursor leading to persistent hypereosinophilia in blood, bone marrow and peripheral tissues.
M.P. Flagiello, M. Schirru, A. Calvisi, A. Cucca, A. Uras, R. Asproni, M. Monne, A. Galitzia, M. Murineddu, M. Bacciocchi, S. Chiriu, L. Deiana, L. Malloci, A. Virdis, A. Palmas, G. Piras.   +15 more
doaj  

Illuminating Insomnia: A Scientometric Exploration of Complementary and Alternative Medicine in Treatment Research. [PDF]

J Lifestyle Med
Singh A, Bhattacharya S, Rishi NN, Bharti S, Gupta SK, Gupta N, Sahish S, Sahu P, Sahu H, Amrute A, Sharma N, Kumar S, Nalge T, Sharma A.   +13 more
europepmc   +1 more source

Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study. [PDF]

Breast Cancer Res Treat
Tolosa P, García-Fructuoso I, Pascual T, Martínez-Sáez O, Cejalvo JM, Servitja S, Fernández Abad M, Benitez Fuentes JD, Brasó-Maristany F, Sanfeliu E, Lema L, Ruano Y, Parrilla L, Roncero AM, Cobos MÁ, Díaz I, Centelles López KA, Sánchez-Bayona R, Alva M, Madariaga A, Villacampa G, Salvador F, Sánchez-Belmonte A, Malumbres M, Prat A, Ciruelos E.   +25 more
europepmc   +1 more source

P152 | IMPACT OF POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTATION FROM A HAPLOIDENTICAL DONOR, MUD OR MMUD. SINGLE-CENTER EXPERIENCE AT THE TRANSPLANT AND CELLULAR THERAPY CENTER, GOM, REGGIO CALABRIA

Haematologica
Background The introduction of post-transplant cyclophosphamide (PTCy) has improved outcomes in haploidentical hematopoietic stem cell transplantation (HSCT), reducing non-relapse mortality (NRM) and preventing graft-versus-host disease (GVHD).
G. Lazzaro, M.C. Micò, G. Policastro, G. Porto, E. Bilardi, F. Cogliandro, C. Argirò, G. Utano, A. Costa, G. D'arrigo, M. Gori, A. Pitino, G. Tripepi, M. Martino   +13 more
doaj  

A commentary on "High prevalence of metabolic comorbidities in Asian children with type 1 diabetes and obesity&quot. [PDF]

Ann Pediatr Endocrinol Metab
Lim HH.
europepmc   +1 more source

P225 | IMPROVED OUTCOME WITH AVAPRITINIB VS MIDOSTAURIN IN SYSTEMIC MASYOCYTOSIS: A SINGLE-CENTER EXPERIENCE

Haematologica
BACKGROUND: Adverse systemic mastocytosis (AdvSM) includes the most aggressive SM subtypes; cKITD816V is recognized as a driver mutation in ~95% of cases. Therefore, Tyrosine Kinase Inhibitors (TKIs) represent the standard of care. Avapritinib is a new,
M. Fazio, S. Stella, T. Chiara, B. Esposito, A. Duminuco, F. Di Raimondo, A. Romano   +6 more
doaj